FeesSafety
Pluang+

The Andersons to present at Stephens Investment Conference, highlights Q3 earnings and Harvestone acquisition

Market News
11 Nov 2026, 23:05 WIB
PRNewsWire
View Source
Bullish
The Andersons to present at Stephens Investment Conference, highlights Q3 earnings and Harvestone acquisition

The Andersons, Inc. announced it will present at the Stephens Annual Investment Conference on November 18, 2026, with CEO Bill Krueger and CFO Brian Valentine speaking. The company highlighted its record third-quarter earnings and recent acquisition of Harvestone Low Carbon Partners, emphasizing progress toward long-term growth and shareholder value. The presentation will be broadcast live and available for replay. This event underscores The Andersons' focus on expanding its agribusiness and renewables sectors.

The Andersons' upcoming presentation at the Stephens Annual Investment Conference provides context for market activity. For readers following US stocks on Pluang, here is the market snapshot as of Nov 12, 2026 03:31 WIB: out of 150 priced stocks, 96 rose and 52 fell. Notable movers include AMD at USD 554.80 with a 1-day change of +7.68% and a typical hold time of 93 days, SNAP at USD 5.36 up 7.20% with 100% buy order activity, and ZM at USD 97.40 rising 7.14% but with 100% sell order activity and a 93-day hold time.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
2 hours ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
3 hours ago
Pyth Network adds real-time NYSE stock data, boosting tokenized stock trading accuracy.

Pyth Network adds real-time NYSE stock data, boosting tokenized stock trading accuracy.

Pyth Network has integrated real-time stock and ETF data from five NYSE exchanges into its marketplace, enhancing its institutional market-data services. This expansion follows its earlier Nasdaq integration, providing developers a unified source for...

Protocol Fundamentals
Bullish
5 hours ago
Innovative Holdings Alliance rebrands as Premergy, shifts focus to battery tech under new ticker PMGY.

Innovative Holdings Alliance rebrands as Premergy, shifts focus to battery tech under new ticker PMGY.

Innovative Holdings Alliance, Inc. has changed its name to Premergy, Inc. and will trade under the new ticker symbol PMGY starting November 12, 2026. This rebranding aligns the company with its focus on advanced battery technology and power-managemen...

Company Fundamentals
Neutral
5 hours ago
AMH declares Q4 2026 dividend of $0.33 per common share, payable Dec 31.

AMH declares Q4 2026 dividend of $0.33 per common share, payable Dec 31.

AMH announced a dividend of $0.33 per common share for Q4 2026, payable in cash on December 31 to shareholders of record as of December 15. Additionally, quarterly distributions were declared for preferred shares: $0.36719 for Series G and $0.39063 f...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App